Edition:
India

Cesca Therapeutics Inc (KOOL.OQ)

KOOL.OQ on NASDAQ Stock Exchange Capital Market

2.88USD
23 Feb 2018
Change (% chg)

$0.02 (+0.70%)
Prev Close
$2.86
Open
$2.86
Day's High
$2.88
Day's Low
$2.85
Volume
931
Avg. Vol
15,259
52-wk High
$6.43
52-wk Low
$2.55

Chart for

About

Cesca Therapeutics Inc. is clinical-stage biotechnology company. The Company develops and markets integrated cellular therapies and delivery systems. The Company is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and... (more)
No analyst recommendations are available for .

Overall

Beta: -0.75
Market Cap(Mil.): $45.06
Shares Outstanding(Mil.): 9.95
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-Cesca Therapeutics Files For Common Stock Offering Of Up To $15 Mln

* FILES FOR COMMON STOCK OFFERING OF UP TO $15 MILLION - SEC FILING Source text: (http://bit.ly/2E1uKu2) Further company coverage:

24 Jan 2018

BRIEF-Cesca Therapeutics Announces Proposed Public Offering Of Common Stock

* CESCA THERAPEUTICS INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage:

29 Nov 2017

BRIEF-Cesca Therapeutics appoints Joe Balagot as senior vice president of corporate development

* Cesca Therapeutics appoints healthcare investment banking veteran Joe E. Balagot as senior vice president of corporate development Source text for Eikon: Further company coverage:

22 Nov 2017

BRIEF-Cesca Therapeutics reports quarterly loss per share $0.24

* Cesca Therapeutics announces financial results for the three months ended September 30, 2017 and provides corporate update

15 Nov 2017

BRIEF-Cesca Therapeutics ‍receives Notice of Allowance for U.S. patent application covering a novel method of cell separation​

* Cesca Therapeutics Inc - ‍receives Notice of Allowance for U.S. patent application covering a novel method of cell separation​ Source text for Eikon: Further company coverage:

03 Oct 2017

Earnings vs. Estimates